On the role of antigen in maintaining cytotoxic T-cell memory. 1996

T M Kündig, and M F Bachmann, and S Oehen, and U W Hoffmann, and J J Simard, and C P Kalberer, and H Pircher, and P S Ohashi, and H Hengartner, and R M Zinkernagel
Institute of Experimental Immunology, University of Zürich, Switzerland.

This study evaluated whether T-cell memory reflects increased precursor frequencies of specific long-lived T cells and/or a low-level immune response against some form of persistent antigen. Antivirally protective CD8+ T-cell memory was analyzed mostly in the original vaccinated host to assess the role of antigen in its maintenance. T-cell mediated resistance against reinfection was measured in the spleen and in peripheral solid organs with protocols that excluded protection by antibodies. In vivo protection was compared with detectable cytotoxic T-lymphocyte precursor frequencies determined in vitro. In the spleen, in vitro detectable cytotoxic T-lymphocyte precursor frequencies remained stable independently of antigen, conferring resistance against viral replication in the spleen during reinfection. In contrast, T-cell mediated resistance against reinfection of peripheral solid organs faded away in an antigen-dependent fashion within a few days or weeks. We show that only memory T cells persistently or freshly activated with antigen efficiently extravasate into peripheral organs, where cytotoxic T lymphocytes must be able to exert effector function immediately; both the capacity to extravasate and to rapidly exert effector function critically depend on restimulation by antigen. Our experiments document that the duration of T-cell memory protective against peripheral reinfection depended on the antigen dose used for immunization, was prolonged when additional antigen was provided, and was abrogated after removal of antigen. We conclude that T-cell mediated protective immunity against the usual peripheral routes of reinfection is antigen-dependent.

UI MeSH Term Description Entries
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008217 Lymphocytic choriomeningitis virus The type species of ARENAVIRUS, part of the Old World Arenaviruses (ARENAVIRUSES, OLD WORLD), producing a silent infection in house and laboratory mice. In humans, infection with LCMV can be inapparent, or can present with an influenza-like illness, a benign aseptic meningitis, or a severe meningoencephalomyelitis. The virus can also infect monkeys, dogs, field mice, guinea pigs, and hamsters, the latter an epidemiologically important host. LCM Viruses,LCMV,LCM Virus,Lymphocytic choriomeningitis viruses
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D014616 Vaccinia virus The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS. Buffalopox virus,Poxvirus officinale,Rabbitpox virus,Buffalo Pox Virus,Rabbit Pox Virus,Buffalo Pox Viruses,Buffalopox viruses,Rabbit Pox Viruses,Rabbitpox viruses,Vaccinia viruses,Virus, Buffalo Pox,Viruses, Buffalo Pox,virus, Buffalopox
D014762 Viral Interference A phenomenon in which infection by a first virus results in resistance of cells or tissues to infection by a second, unrelated virus. Interference, Viral,Interferences, Viral,Viral Interferences

Related Publications

T M Kündig, and M F Bachmann, and S Oehen, and U W Hoffmann, and J J Simard, and C P Kalberer, and H Pircher, and P S Ohashi, and H Hengartner, and R M Zinkernagel
January 1994, Developments in biological standardization,
T M Kündig, and M F Bachmann, and S Oehen, and U W Hoffmann, and J J Simard, and C P Kalberer, and H Pircher, and P S Ohashi, and H Hengartner, and R M Zinkernagel
June 1994, Nature,
T M Kündig, and M F Bachmann, and S Oehen, and U W Hoffmann, and J J Simard, and C P Kalberer, and H Pircher, and P S Ohashi, and H Hengartner, and R M Zinkernagel
April 2000, International immunology,
T M Kündig, and M F Bachmann, and S Oehen, and U W Hoffmann, and J J Simard, and C P Kalberer, and H Pircher, and P S Ohashi, and H Hengartner, and R M Zinkernagel
March 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences,
T M Kündig, and M F Bachmann, and S Oehen, and U W Hoffmann, and J J Simard, and C P Kalberer, and H Pircher, and P S Ohashi, and H Hengartner, and R M Zinkernagel
April 1996, Immunological reviews,
T M Kündig, and M F Bachmann, and S Oehen, and U W Hoffmann, and J J Simard, and C P Kalberer, and H Pircher, and P S Ohashi, and H Hengartner, and R M Zinkernagel
February 1997, European journal of immunology,
T M Kündig, and M F Bachmann, and S Oehen, and U W Hoffmann, and J J Simard, and C P Kalberer, and H Pircher, and P S Ohashi, and H Hengartner, and R M Zinkernagel
June 2005, Journal of immunology (Baltimore, Md. : 1950),
T M Kündig, and M F Bachmann, and S Oehen, and U W Hoffmann, and J J Simard, and C P Kalberer, and H Pircher, and P S Ohashi, and H Hengartner, and R M Zinkernagel
January 1994, The Journal of experimental medicine,
T M Kündig, and M F Bachmann, and S Oehen, and U W Hoffmann, and J J Simard, and C P Kalberer, and H Pircher, and P S Ohashi, and H Hengartner, and R M Zinkernagel
May 2013, Journal of immunology (Baltimore, Md. : 1950),
T M Kündig, and M F Bachmann, and S Oehen, and U W Hoffmann, and J J Simard, and C P Kalberer, and H Pircher, and P S Ohashi, and H Hengartner, and R M Zinkernagel
August 2006, Immunological reviews,
Copied contents to your clipboard!